Similar Items: A diagnostic plasma omics‐biomarker for Alzheimer's disease informed by microglial single‐cell transcriptomics: A pilot study
- Heritability of Alzheimer's disease–related plasma biomarkers in the Amish population
- A fovea‐centered retinal signature linked to plasma biomarkers in prodromal Alzheimer's disease
- The effect of treating hearing loss with hearing aids on plasma biomarkers of Alzheimer's disease and related dementias
- Pharmacokinetic/pharmacodynamic analyses of plasma pathophysiology biomarkers in subjects with early Alzheimer's disease following lecanemab treatment
- Currently Available Biomarkers and Strategies for the Validation of Novel Candidates for Neurochemical Dementia Diagnostics in Alzheimer’s Disease and Mild Cognitive Impairment
- CSF Biomarkers of Alzheimer’s Disease: Impact on Disease Concept, Diagnosis, and Clinical Trial Design